Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-04-002478
Filing Date
2004-03-05
Accepted
2004-03-05 11:11:44
Documents
1
Period of Report
2004-02-27

Document Format Files

Seq Description Document Type Size
1 v01877-gury_ex.html 3  
1 v01877-gury_ex.xml 3 2641
  Complete submission text file 0001144204-04-002478.txt   4503
Mailing Address 12085 RESEARCH DRIVE ALACHUA FL 32615
Business Address 12085 RESEARCH DRIVE ALACHUA FL 32615 3864184018
ORAGENICS INC (Issuer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NABI PHARMACEUTICALS 5800 PARK OF COMMERCE BLVD N.W. BOCA RATON FL 33487
Business Address NABI PHARMACEUTICALS 5800 PARK OF COMMERCE BLVD N.W. BOCA RATON FL 33487 5619895800
GURY DAVID J (Reporting) CIK: 0001206466 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50614 | Film No.: 04650814